See Also: Publications
- Biosecurity and Bioterrorism Special Feature: A Decade in Biosecurity. Various authors. Biosecurity and Bioterrorism. 2012;10(1):5-88. This series of 7 review articles by leaders in the field was commissioned by the Sloan Foundation to document achievements of the past decade and help chart the direction of future efforts.
- "Sunday Dialogue: Bird Flu Experiments." Inglesby TV. Sunday Dialogue: Bird Flu Experiments. New York Times. January 29, 2012. Letters.
- "Engineered H5N1: A Rare Time for Restraint in Science." Inglesby TV. Annals of Internal Medicine. March 20, 2012;156(6):460-462. First published January 26, 2012 on annals.org.
- "Preventing Pandemics: The Fight Over Flu." Fouchier R, Osterhaus AB, Steinbruner J, Yuen KY, Henderson DA, et al. Nature. 15 January 2012;481(7381):257-259.
- "Life Sciences at a Crossroads: Respiratory Transmissible H5N1." Osterholm MT and Henderson DA. Science. Published ahead of print January 19, 2012. DOI: 10.1126/science.1218612.
- "Editorial: The Risk of Engineering a Highly Transmissible H5N1 Virus." Inglesby TV, Cicero A, and Henderson DA. www.upmc-biosecurity.org. December 15, 2011.
- "Diagnostics for Global Biosurveillance: Turning Promising Science into the Tools Needed in the Field." Nuzzo J, Rambhia K, Wollner S, et al. Center for Biosecurity of UPMC. September 2011.
- "Center for Biosecurity Meets with Chinese Leaders in Public Health and Science." Inglesby TV and Cicero A. www.upmc-biosecurity.org. September 2011.
- "Contagion--Public Health's Top Gun." Toner E, Cicero A, Adalja A, and Inglesby TV. www.upmc-biosecurity.org. September 2011.
- "A Crossroads in Biosecurity: Steps to Strengthen U.S. Preparedness." Center for Biosecurity, September 2011.
- "Progress in Disaster Planning and Preparedness Since 2001." Inglesby TV. The Journal of the American Medical Association, Published online September 8, 2011. doi: 10.1001/jama.2011.1359.
- "A Crossroads in Biosecurity." Various authors. Crossroads in Biosecurity: Steps to Strengthen U.S. Preparedness. Center for Biosecurity of UPMC. September 8, 2011.
- "Preparing Hospitals for Large-Scale Infectious Disease Emergencies." Toner E and Adalja AA.In Crossroads in Biosecurity: Steps to Strengthen U.S. Preparedness. Center for Biosecurity of UPMC. September 8, 2011: 28-31.
- "Post-9/11 Challenges of a Crisis." Henderson DA. In Crossroads in Biosecurity: Steps to Strengthen U.S. Preparedness. Center for Biosecurity of UPMC. September 8, 2011:8-11.
- "Managing the Insider Threat in High-Containment Laboratories ." Gronvall GK. In Crossroads in Biosecurity: Steps to Strengthen U.S. Preparedness. Center for Biosecurity of UPMC. September 8, 2011:12-15.
See Also: Multimedia
- Panel 3: Transformative Science in Biosecurity. Panel discussion moderated by Tom Inglesby at the conference, Charting the Future of Biosecurity Ten Years After the Anthrax Attacks, October 4, 2011.
- U.S. Government Programs & Priorities, Part 1. Panel discussion moderated by Thomas V. Inglesby at the conference "Preserving National Security: The Growing Role of the Life Sciences," March 3, 2011.
- U.S. Government Programs & Priorities, Part 2. Panel discussion moderated by Gigi Kwik Gronvall at the conference, "Preserving National Security: The Growing Role of the Life Sciences," March 3, 2011.
- FDA Strategy for Medicines & Vaccines of Importance to National Security. Margaret Hamburg, Commissioner, U.S. FDA. Remarks delivered at the conference, "Preserving National Security: The Growing Role of the Life Sciences," March 3, 2011.
- Life Science Contributions to the 21st Century. Alan I. Leshner, CEO, American Association for the Advancement of Science and Executive Publisher of Science. Remarks delivered at the conference, "Preserving National Security: The Growing Role of the Life Sciences," March 3, 2011.
- Life Sciences Rising. Opening remarks delivered by Thomas V. Inglesby for the conference, "Preserving National Security: The Growing Role of the Life Sciences," March 3, 2011.
- Science Diplomacy for Global Security: Current Initiatives & Future Possibilities. Panel discussion moderated by D. A. Henderson at the conference "Preserving National Security: The Growing Role of the Life Sciences, March 3, 2011.
- What's Next? Life Science Trends Worth Watching. Panel discussion moderated by Gigi Kwik Gronvall at the conference, "Preserving National Security: The Growing Role of the Life Sciences," March 3, 2011.
- Maintaining U.S. Competitiveness in the Life Sciences—What Will It Take? Panel discussion moderated by Anita Cicero at the conference, "Preserving National Security: The Growing Role of the Life Sciences," March 3, 2011.
- DoD Biodefense Challenges and Accomplishments. Andrew C. Weber, Asst. to the Secretary of Defense for Nuclear and Chemical and Biological Defense Programs, DoD. Remarks delivered at the conference, "The State of Biopreparedness: Lessons from Leaders, Proposals for Progress," September 23, 2010.
Interact With Us
Home > Our Work > National Security > Topics in Biosecurity
Countermeasures
- Biosecurity and Bioterrorism Special Feature: A Decade in Biosecurity. Various authors. Biosecurity and Bioterrorism. 2012;10(1):5-88. This series of 7 review articles by leaders in the field was commissioned by the Sloan Foundation to document achievements of the past decade and help chart the direction of future efforts.
- Panel 2: Looking Ahead in U.S. Health Security. Panel discussion moderated by Richard Besser, ABC News, at the conference, Charting the Future of Biosecurity Ten Years After the Anthrax Attacks, October 4, 2011.
- BioCentury TV, Tom Inglesby Interview Center Director Dr. Tom Inglesby was a panelist on BioCentury This Week, September 18, 2011.
- "Contagion--Public Health's Top Gun." Toner E, Cicero A, Adalja A, and Inglesby TV. www.upmc-biosecurity.org. September 2011.
- "Four Ways to Reduce the Time and Cost of Anthrax Cleanup." Franco C. In Crossroads in Biosecurity: Steps to Strengthen U.S. Preparedness. Center for Biosecurity of UPMC. September 8, 2011: 32-35.
- "A New Framework for Influenza—Rational Use of Antiviral Therapy and Vaccines." Adalja AA. US Respiratory Disease. 2011;7(1):49–52.
- "Book Review: Deadly Choices--How the Anti-Vaccine Movement Threatens Us All." Adalja AA. The Journal of the American Medical Association. 2011;305(23):2469.
- "Smallpox Virus Destruction and the Implications of a New Vaccine." Henderson DA. Biosecurity and Bioterrorism. 2011;9(2):163-168.
- "Vaccines, Immunity, Whooping Cough, and Mumps." Adalja AA. Biosecurity and Bioterrorism. 2011;9(1):9-11.
- FDA Strategy for Medicines & Vaccines of Importance to National Security. Margaret Hamburg, Commissioner, U.S. FDA. Remarks delivered at the conference, "Preserving National Security: The Growing Role of the Life Sciences," March 3, 2011.
- Anticipating the Impact of Bruesewitz v. Wyeth on Vaccine and Medical Countermeasure Injury Compensation and Availability." Courtney B and Morhard R. Biosecurity and Bioterrorism. 2010;8(4):315-320.
- "The State of Biopreparedness: Conference Report." Franco C and Hansen MB. Biosecurity and Bioterrorism. 2010;8(4):379-384.
- How Prepared Is the Nation to Dispense Medical Countermeasures Rapidly to Large Populations? Panel discussion moderated by Brooke Courtney, at the conference "The State of Biopreparedness," September 23, 2010.
- DHS Biodefense Programs and Priorities: Now and in the Years Ahead. Alexander Garza, Assistant Secretary for Health Affairs and Chief Medical Officer, DHS. Remarks delivered at the conference,"The State of Biopreoaredness: Lessons for Leaders, Proposals for Progress," September 23, 2010.
- U.S. Biopreparedness. Kathleen Sebelius, Secretary of DHHS. Remarks delivered at the conference, "The State of Biopreparedness: Lessons from Leaders, Proposals for Progress," September 23, 2010.
- Biodefense--Strengthening the Chain of Resilience. Senator Bob Graham, Co-founder, The WMD Center, and former Chairman, WMD Commission. Remarks delivered at the conference, "The State of Biopreparedness: Lessons for Leaders, Proposals for Progress," September 23, 2010.
- DoD Biodefense Challenges and Accomplishments. Andrew C. Weber, Asst. to the Secretary of Defense for Nuclear and Chemical and Biological Defense Programs, DoD. Remarks delivered at the conference, "The State of Biopreparedness: Lessons from Leaders, Proposals for Progress," September 23, 2010.
- How Should the U.S. Prioritize & Distribute Vaccine in Future Influenza Pandemics? Panel discussion moderated by Richard Waldhorn at the conference, "The 2009 H1N1 Experience: Policy Implications for Future Infectious Disease Emergencies," March 5, 2010.
- 2009 H1N1 Issue Brief: "International Progress in Vaccine Development and Distribution." Rambhia K and Jennifer Nuzzo, December 17, 2009.
- "Influenza Vaccine Production for the U.S. Market." Smith LM and Gronvall GK. Biosecurity and Bioterrorism. 2009;7(3):259-263.
- 2009 H1N1 Issue Brief: "Licensure, Evaluation and Adverse Event Monitoring of the 2009 H1N1 Influenza Vaccine." Watson M and Nuzzo J, November 13, 2009.
- Biodefense and Resilience. Panel discussion moderated by Thomas Inglesby for the conference, "Prevention of Biothreats: A Look Ahead," October 6, 2009.
- "BARDA Funding Requirements." Economic analysis of BARDA funding requirements, July 2009.
- "Drug and Vaccine Development for Infectious Diseases: The Value of Priority Review Vouchers." Matheny J, Smith B, Courtney B, and Mair M. Clinical Pharmacology & Therapeutics. 2009;85(6):571–572.
- "The Use of Antivirals for 2009 H1N1 Influenza Virus Infection." Norwood A, Courtney B, Toner E, and Adalja A, May 13, 2009.
- "FDA Emergency Use Authorizations (EUAs): What Are They and What Do They Mean for the Swine Flu Response?" Courtney B, April 29, 2009.
- "Biosecurity Memos to the Obama Administration." O'Toole T and Inglesby TV, et al., March 2009.
- "Developing Medical Countermeasures for Biodefense." Smith B, Mair M, Gronvall GK, and Matheny J. Biosecurity and Bioterrorism. 2009;7(1):42-44.
- "Maximizing State and Local Medical Countermeasure Stockpile Investments Through the Shelf-Life Extension Program." Courtney B, Easton J, Inglesby TV, and SooHoo C. Biosecurity and Bioterrorism. 2009;7(1):101-107.
- "Strategic Priorities for U.S. Biosecurity." O'Toole T and Inglesby TV. Biosecurity and Bioterrorism. 2009;7(1):25-28.
- "Letter to President Obama: BARDA FY2010 Funding Recommendation." The Center recommends to President Obama that BARDA receive $1.7 billion in FY 2010, March 2009.
- "Letter to U.S. Senate: BARDA FY2010 Funding Recommendation." The Center recommends to the U.S. Senate that BARDA receive $1.7 billion in FY 2010, March 2009.
- "Letter to U.S. House of Representatives: BARDA FY2010 Funding Recommendation." The Center's recommends to the U.S. House that BARDA receive $1.7 billion in FY 2010, March 2009.
- "Comments on Designating Additions to the Current List of Tropical Diseases in the Food and Drug Administration Amendments Act." The Center's comments on Docket No. FDA-2008-N-0567: Designating Additions to the Current List of Tropical Diseases in the Food and Drug Administration Amendments Act, February 2009.
- "Letter of Support for Increase of BARDA Funding." Center for Biosecurity letter of endorsement, September 2008.
- "Cost/Success Projections for US Biodefense Countermeasure Development." Matheny J, Mair M, and Smith B. Nature Biotechnology. 2008;26(9):981-983.
- "Recommendations for BARDA funding for FY2009." At Senator Burr's request, the Center recommended levels of funding needed for BARDA to succeed in 2009 and beyond, March 2008.
- "Biodefense Countermeasures: The Impact of Title IV of the US Pandemic and All-Hazards Preparedness Act." Gronvall GK. Emerging Health Threats Journal. 2008;1:e3. doi: 10.3134/ehtj.08.003.
- "Avian Influenza: Critical Program Issues." Yansen S, Safi B, Nuzzo J, and Barnett D. Global Health Technical Brief (Prepared for the United States Agency for International Development). February 2008.
- "BARDA FY09 Advanced Development Cost Estimates for Medical Countermeasures Against Biological Threats." Preliminary economic analysis of BARDA funding, January 2008.
- "Summary of HSPD-21." Mair M and Franco C, October 2007.
- "Six Years After Anthrax: Are We Better Prepared to Respond to Bioterrorism?" Tara O'Toole testified before the Senate Committee on Homeland Security and Governmental Affairs, October 2007.
- "Letter to Editor: The FDA Animal Efficacy Rule and Biodefense." Gronvall GK, Trent D, Borio L, et al. Nature Biotechnology. 2007;25:1084-1087.
- "Flexible Defenses Roundtable Meeting: Promoting the Strategic Innovation of Medical Countermeasures." Gronvall GK, Matheny J, Smith B, et al. Biosecurity and Bioterrorism. 2007;5(3):271-277.
- "Incentives for Biodefense Countermeasure Development." Matheny J, Mair M, Mulcahy A and Smith B. Biosecurity and Bioterrorism. 2007;5(3):228-238.
- "Immune-Boosting Adjuvants." Chamberlain A and Gronvall GW. Biosecurity and Bioterrorism. 2007;5(3):202-205.
- "Biomedical Advanced Research and Development Authority (BARDA) Roundtable." Gronval GK, Smith B, Matheny J, et al. Biosecurity and Bioterrorism. 2007;5(2):174-179.
- "The Science of Biodefense: RNAi." Chamberlain A and Gronvall GK. Biosecurity and Bioterrorism. 2007;5(2):104-106.
- Issue Brief: "Global Biotechnology and Pharmaceutical Industries," Matheny J, January 2007.
- "Getting Medicine to Millions: New Strategies for Mass Distribution." Lien O, Maldin B, Franco C, and Gronvall GK. Biosecurity and Bioterrorism. 2006;4(2):176-182.